Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Teng‐Jia Jiang"'
Autor:
Qi Zhao, Feng Wang, Yan-Xing Chen, Shifu Chen, Yi-Chen Yao, Zhao-Lei Zeng, Teng-Jia Jiang, Ying-Nan Wang, Chen-Yi Wu, Ying Jing, You-Sheng Huang, Jing Zhang, Zi-Xian Wang, Ming-Ming He, Heng-Ying Pu, Zong-Jiong Mai, Qi-Nian Wu, Renwen Long, Xiaoni Zhang, Tanxiao Huang, Mingyan Xu, Miao-Zheng Qiu, Hui-Yan Luo, Yu-Hong Li, Dong-Shen Zhang, Wei-Hua Jia, Gong Chen, Pei-Rong Ding, Li-Ren Li, Zheng-Hai Lu, Zhi-Zhong Pan, Rui-Hua Xu
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
The ChangKang (Heathy Bowel) project was established to collect molecular and clinical information of a thousand Chinese colorectal cancer patients. Here, the authors present the genomic landscape of the ChangKang cohort and find a subgroup of patien
Externí odkaz:
https://doaj.org/article/ee0548bf4a574cba8d5b0964a7e38b91
Autor:
Teng‐Jia Jiang, Fang Wang, Ying‐Nan Wang, Jia‐Jia Hu, Pei‐Rong Ding, Jun‐Zhong Lin, Zhi‐Zhong Pan, Gong Chen, Jian‐Yong Shao, Rui‐hua Xu, Qi Zhao, Feng Wang
Publikováno v:
Cancer Communications, Vol 40, Iss 11, Pp 620-632 (2020)
Abstract Background Inherited susceptibility accounts for nearly one‐third of colorectal cancer (CRC) predispositions and has an 80%‐100% lifetime risk of this disease. However, there are few data about germline mutations of hereditary CRC‐rela
Externí odkaz:
https://doaj.org/article/39a15601ed8e4c13860efc5397ddad0a
Autor:
Yan‐Xing Chen, Zi‐Xian Wang, Shu‐Qiang Yuan, Teng‐Jia Jiang, You‐Sheng Huang, Rui‐Hua Xu, Feng Wang, Qi Zhao
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/b915738d37a5444facd0e60cedcf9b20
Autor:
Zhizhong Pan, Pei-Rong Ding, Rui-Hua Xu, Ying-Nan Wang, Fang Wang, Qi Zhao, Gong Chen, Teng-Jia Jiang, Junzhong Lin, Jian Yong Shao, Jia-jia Hu, Feng Wang
Publikováno v:
Cancer Communications
Cancer Communications, Vol 40, Iss 11, Pp 620-632 (2020)
Cancer Communications, Vol 40, Iss 11, Pp 620-632 (2020)
Background Inherited susceptibility accounts for nearly one‐third of colorectal cancer (CRC) predispositions and has an 80%‐100% lifetime risk of this disease. However, there are few data about germline mutations of hereditary CRC‐related genes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef666eb02079b8cad3e192477fb8d6b1
https://doi.org/10.1002/cac2.12093
https://doi.org/10.1002/cac2.12093
Autor:
Zi-Xian Wang, Shu-Qiang Yuan, Feng Wang, Qi Zhao, Yan-Xing Chen, You-Sheng Huang, Rui-Hua Xu, Teng-Jia Jiang
Publikováno v:
Clinical and Translational Medicine
Clinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
Clinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452a6dd4b369879f914531c64e4e16dd
http://europepmc.org/articles/PMC8473642
http://europepmc.org/articles/PMC8473642
Autor:
Lu-Ping Yang, Teng-Jia Jiang, Ming-ming He, Qi Zhao, Yihong Ling, Zi-xian Wang, Hao-Xiang Wu, Ying Jin, Zhen Zhang, Rui-hua Xu, Feng Wang
Publikováno v:
Journal of Clinical Oncology. 40:e15555-e15555
e15555 Background: Synchronous colorectal cancer (SCRC) refers to a special group of CRC with at least two primary tumors detected simultaneously in one patient, with 90% being sporadic. Although the systemic treatments of late-stage SCRC are mainly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e95f86bcca14afa9a268946b02e05c10
https://doi.org/10.1200/jco.2022.40.16_suppl.e15555
https://doi.org/10.1200/jco.2022.40.16_suppl.e15555
Autor:
Qi Zhao, Feng Wang, Yan-Xing Chen, Shifu Chen, Yi-Chen Yao, Zhao-Lei Zeng, Teng-Jia Jiang, Ying-Nan Wang, Chen-Yi Wu, Ying Jing, You-Sheng Huang, Jing Zhang, Zi-Xian Wang, Ming-Ming He, Heng-Ying Pu, Zong-Jiong Mai, Qi-Nian Wu, Renwen Long, Xiaoni Zhang, Tanxiao Huang, Mingyan Xu, Miao-Zheng Qiu, Hui-Yan Luo, Yu-Hong Li, Dong-Shen Zhang, Wei-Hua Jia, Gong Chen, Pei-Rong Ding, Li-Ren Li, Zheng-Hai Lu, Zhi-Zhong Pan, Rui-Hua Xu
Publikováno v:
Nature communications. 13(1)
The genetic basis of colorectal cancer (CRC) and its clinical associations remain poorly understood due to limited samples or targeted genes in current studies. Here, we perform ultradeep whole-exome sequencing on 1015 patients with CRC as part of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44973b0854890cb48537eca04a60dabf
https://pubmed.ncbi.nlm.nih.gov/35487942
https://pubmed.ncbi.nlm.nih.gov/35487942
Autor:
Feng, Wang, Tian-Shu, Liu, Xiang-Lin, Yuan, Hui-Yan, Luo, Kang-Sheng, Gu, Ying, Yuan, Yan-Hong, Deng, Jian-Ming, Xu, Yu-Xian, Bai, Ying, Wang, Wang-Jun, Liao, He-Long, Zhang, Feng, Bi, Bang-Mao, Wang, Zhi-Xiang, Zhuang, Teng-Jia, Jiang, Rui-Hua, Xu
Publikováno v:
Am J Cancer Res
Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44f1f521593beedd3de4f9455647b7f0
https://pubmed.ncbi.nlm.nih.gov/33042632
https://pubmed.ncbi.nlm.nih.gov/33042632
Autor:
Zhizhong Pan, Qi Zhao, Feng Wang, Jian Yong Shao, Fu-rong Liu, Teng-Jia Jiang, Pei-Rong Ding, Jia-jia Hu, Ying-Nan Wang, Rui-Hua Xu
Publikováno v:
Cancer Research. 79:4161-4161
Background/Aims: Colorectal cancer (CRC) is a common cancer worldwide with increasing morbidity in China. Approximately 5% CRC are caused by well-defined hereditary CRC syndromes, whose inherited susceptibility account for nearly one-third of CRC pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae48c7b897692cd37060caeb2b568280
https://doi.org/10.1158/1538-7445.am2019-4161
https://doi.org/10.1158/1538-7445.am2019-4161